Internal Medicine, Endocrinology, Diabetes, & Metabolism · Philadelphia, PA
NPI
1659571925
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3400 Spruce St, 1 Maloney
Philadelphia, PA, 19104
Phone (215) 746-6391
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,171 services
Medicare patients, 2024
370
Average age 72
Drug cost, 2024
$1.4M
2,708 prescriptions
Company payments, 2025
$15.13
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Artit A Silpasuvan was code 99214 (office e&m - established), 277 times for 205 patients. In total Artit A Silpasuvan billed 1,171 services in 26 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 277 | 205 | $95.61 | $26K |
| 82962 Clinical Chemistry | Office | 169 | 108 | $3.17 | $536 |
| 99215 Office E&M - Established | Office | 136 | 106 | $136.47 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 125 | 116 | $13.33 | $1,667 |
| 83036 Blood Count | Office | 87 | 66 | $9.41 | $819 |
| 99205 Office E&M - New | Office | 39 | 39 | $174.41 | $6,802 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 16 | $64.21 | $2,311 |
| 99222 Hospital E&M - Initial | Facility | 35 | 34 | $100.72 | $3,525 |
| 99204 Office E&M - New | Office | 19 | 19 | $114.34 | $2,172 |
| 99213 Office E&M - Established | Office | 18 | 15 | $67.35 | $1,212 |
By year: 2022 $68K for 1,088 services; 2023 $70K for 1,226 services; 2024 $71K for 1,171 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 169 | 108 | $3.17 | $536 |
| 83036 Blood Count | 87 | 66 | $9.41 | $819 |
Medicare prescription drug claims, 2024
In 2024, the drug Artit A Silpasuvan prescribed most often to Medicare patients was Ozempic (Semaglutide), with 257 prescriptions and refills. In total Artit A Silpasuvan wrote 2,708 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 257 | 375 | 60 | $357K |
| Levothyroxine Sodium Generic | 212 | 540 | 61 | $1,966 |
| Jardiance Empagliflozin | 131 | 221 | 33 | $127K |
| Methimazole Generic | 106 | 267 | 28 | $1,717 |
| Trulicity Dulaglutide | 104 | 153 | 27 | $139K |
| Rosuvastatin Calcium Generic | 102 | 258 | 35 | $2,997 |
| Metformin Hcl Generic | 102 | 250 | 36 | $1,037 |
| Atorvastatin Calcium Generic | 89 | 221 | 27 | $1,319 |
| Mounjaro Tirzepatide | 82 | 86 | 17 | $89K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 80 | 173 | 32 | $8,149 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 79 | 183 | 28 | $11K |
| Metformin Hcl Er Metformin Hcl | 74 | 168 | 25 | $870 |
| Amlodipine Besylate Generic | 62 | 184 | 22 | $553 |
| Januvia Sitagliptin Phosphate | 60 | 97 | 11 | $52K |
| Novolog Flexpen Insulin Aspart | 60 | 114 | 20 | $16K |
Brand drugs: 1,352 claims; generic drugs: 1,208 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Artit A Silpasuvan $15.13 ($15.13 in general payments such as food, travel and fees) from 1 company. The largest payer was Amphastar Pharmaceuticals, Inc. with $15.13.
| Company | Payments | Amount |
|---|---|---|
| Amphastar Pharmaceuticals, Inc. AMPH | 1 | $15.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.